Chemistry: molecular biology and microbiology – Micro-organism – tissue cell culture or enzyme using process... – Recombinant dna technique included in method of making a...
Reexamination Certificate
2006-03-28
2006-03-28
Ulm, John (Department: 1646)
Chemistry: molecular biology and microbiology
Micro-organism, tissue cell culture or enzyme using process...
Recombinant dna technique included in method of making a...
C435S252300, C435S320100, C530S350000, C536S023400
Reexamination Certificate
active
07018812
ABSTRACT:
The present invention relates to modified G-protein coupled receptors (GPCRs). The modified GPCRs of the present invention include GPCRs that have been modified to have carboxyl terminal tails comprising one or more sites of phosphorylation, preferably one or more clusters of phosphorylation sites. The modified GPCRs of the present invention may comprise a retained portion of a carboxyl-terminus region from a first GPCR fused to a polypeptide, wherein the polypeptide comprises the one or more clusters of phosphorylation. The present invention also relates to methods of screening compounds and sample solutions for GPCR activity using the modified GPCRs.
REFERENCES:
patent: 3654090 (1972-04-01), Schuurs et al.
patent: 3850752 (1974-11-01), Schuurs et al.
patent: 4016043 (1977-04-01), Schuurs et al.
patent: 4341761 (1982-07-01), Ganfield et al.
patent: RE31006 (1982-08-01), Schuurs et al.
patent: 4342566 (1982-08-01), Theofilopoulos et al.
patent: 4399121 (1983-08-01), Albarella et al.
patent: 4427783 (1984-01-01), Newman et al.
patent: 4444887 (1984-04-01), Hoffmann
patent: 4451570 (1984-05-01), Royston et al.
patent: 4466917 (1984-08-01), Nussenzweig et al.
patent: 4472500 (1984-09-01), Milstein et al.
patent: 4491632 (1985-01-01), Wands et al.
patent: 4493890 (1985-01-01), Morris
patent: 4816397 (1989-03-01), Boss et al.
patent: 4816567 (1989-03-01), Cabilly et al.
patent: 4981784 (1991-01-01), Evans et al.
patent: 5284746 (1994-02-01), Sledziewski et al.
patent: 5366889 (1994-11-01), MacDonald et al.
patent: 5468854 (1995-11-01), McCabe et al.
patent: 5482835 (1996-01-01), King et al.
patent: 5491084 (1996-02-01), Chalfie et al.
patent: 5532157 (1996-07-01), Fink
patent: 5576436 (1996-11-01), McCabe et al.
patent: 5625048 (1997-04-01), Tsien et al.
patent: 5777079 (1998-07-01), Tsien et al.
patent: 5804387 (1998-09-01), Cormack et al.
patent: 5891646 (1999-04-01), Barak et al.
patent: 5958713 (1999-09-01), Thastrup et al.
patent: 5989835 (1999-11-01), Dunlay et al.
patent: 6066476 (2000-05-01), Tsien et al.
patent: 6107324 (2000-08-01), Behan et al.
patent: 6110693 (2000-08-01), Barak et al.
patent: 6140509 (2000-10-01), Behan et al.
patent: 6150393 (2000-11-01), Behan et al.
patent: WO88/03168 (1988-05-01), None
patent: WO94/16684 (1994-08-01), None
patent: WO98/12310 (1998-03-01), None
patent: WO98/44350 (1998-10-01), None
patent: WO99/66324 (1999-12-01), None
patent: WO00/12704 (2000-03-01), None
patent: WO01/58923 (2001-08-01), None
Borle, A.B.,An Overview of Techniques for the Measurement of Calcium Distribution, Calcium Fluxes, and Cytosolic Free Calcium in Mammalian Cells, Environmental Health Perspectives, Mar. 1990, pp. 45-56, vol. 84, U.S. Dept. of Health and Human Services, U.S.A.
Boss, V., et al.,Induction of NFAT-mediated Transcription by Gq-coupled Receptors in Lymphoid and Non-lymphoid Cells, The Journal of Biological Chemistry, May 3, 1996, pp. 10429-10432, vol. 271, No. 18, The American Society for Biochemistry and Molecular Biology, Inc., USA.
Chen, W., et al.,β-Arrestin 2 Mediates Endocytosis of Type III TGF—β Receptor and Down-Regulation of Its Signaling, Science, Sep. 5, 2003, pp. 1394-1397, vol. 301, American Association for the Advancement of Science, USA.
Edge, M.D., et al.,Total synthesis of a human leukocyte interferon gene, NATURE, Aug. 20, 1981, pp. 756-762, vol. 292, No. 5825, American Chemical Society, Macmillian Journals, Ltd.
Inglese, J., et al.,Isoprenylation in regulation of signal transduction by G-protein-coupled receptor kinases, Nature, Sep. 10, 1992, pp. 147-150, vol. 359, No. 6391, Macmillian Journals, Ltd.
Jay, E., et al.,Chemical Synthesis of a Biologically Active Gene for Human Immune Interferon-γ, The Journal of Biological Chemistry, May 25, 1984, pp. 6311-6317, vol. 259, No. 10, The American Society of Biological Chemists, Inc., USA.
Lyons, S., et al.,An immunological method for detecting gene expression in yeast colonies, Proceedings of the National Academy of Sciences USA, Dec. 1984, pp. 7426-7430, vol. 81.
Nambiar, K.P., et al.,Total Synthesis and Cloning of a Gene Coding for the Ribonuclease S Protein, Science, 1984, pp. 1299-1301, vol. 223, Elsevier Science Inc., USA.
Noren, C.J., et al.,A General Method for Site-Specific Incorporation of Unnatural Amino Acids into Proteins, Science, Apr. 14, 1989, pp. 182-188. vol. 244, American Association for the Advancement of Science, USA.
Angers, S., et al.,Detection of β2-Adrenergic receptor dimerization in living cells using bioluminescence resonance energy transfer(BRET),Proceedings of the National Academy of Sciences, vol. 97, No. 7, Mar. 28, 2000, pp. 3684-3689. Proc.Natl. Acad. Sci, USA.
Attramadal, H., et al., β-Arrestin2, a Novel Member of the Arrestin/β-Arrestin Gene Family, Journal of Biological Chemistry, vol. 257, No. 25, Sep. 5, 1992, pp 17882-17890, The American Society for Biochemistry and Molecular Biology, Inc., USA.
Barak, et al.,Abstract #2484, Molecular Biology of the Cell, vol. 7, p. 427a Dec. 1996, 6thInternational Congress on Cell Biology & 36thAmerican Society for Cell Biology Annual Meeting, Dec. 7-11, 1996, San Francisco, CA.
Barak, L.S., et al.,Constitutive arrestin-mediated desensitization of a human vasopressin receptor mutant associated with nephrogenic diabetes insipidus, Proceedings of the National Academy of Sciences, vol. 98, No. 1, Jan. 2, 2001, pp. 93-99, Proc.Natl. Acad. Sci. USA.
Barak, L.S., et al.,A highly Conserved Tyrosine Residue in G Protein-Coupled Receptors is Required for Agonist-mediated β2-Adrenergic Receptor Sequestration, Journal of Biological Chemistry, vol. 269, No. 4, Jan. 28, 1994, pp. 2790-2795, The American Society for Biochemistry and Molecular Biology, Inc., USA.
Barak, L.S., et al.,Aβ-Arrestin/Green Fluorescent Protein Biosensor for Detecting G Protein-coupled Receptor Activation, Journal of Biological Chemistry, vol. 272, No. 44, Oct. 31, 1997, pp. 27497-27500, The American Society for Biochemistry and Molecular Biology, Inc., USA.
Barak, L.S., et al.,The Conserved Seven-Transmembrane Sequence NP(X)2.2Y of the G-Protein-Coupled Receptor Superfamily Regulates Multiple Properties of the β2-Adrenergic Receptor, Biochemistry, vol. 34, No. 47, 1995, pp. 15407-15414.
Barak, L.S., et al.,Internal Trafficking and Surface Mobility of a Functionally Intact β2-Adrenergic Receptor-Green Fluorescent Protein Conjugate, Molecular Pharmacology, 51, 1997, pp. 177-184.
Barak, L.S., et al.,Real-time Visualization of the Cellular Redistribution of G Protein-coupled Receptor Kinase 2 andβ-arrestin 2 during Homologous Desensitization of the Substance P Receptor, Journal of Biological Chemistry, vol. 274, No. 11, Mar. 12, 1999, pp. 7565-7569, The American Society for Biochemistry and Molecular Biology, Inc., USA.
Cubitt, A., et al.,Understanding, Improving and Using Green Fluorescent Proteins, Trends in Biochemical Sciences, International Union of Biochemistry and Molecular Biology, 448-455, 1995, Elsevier Trends Journals, Oxford, UK.
Drews, J.,Drug Discovery: A Historical Perspective, Science, vol. 287, Mar. 17, 2000, pp. 1960-1964, American Association for the Advancement of Science, Washington, D.C.
Ferguson, S.S.G., et al.,G-protein-coupled receptor regulation: role of G-protein-coupled receptor kinases and arrestins, Can. J. Physiol. Pharmacol., vol. 74, 1996, pp. 1095-1110, NRC, Canada.
Ferguson, S.S.G., et al.,Molecular Mechanisms of G Protein-Coupled Receptor Desensitization and Resensitization, Life Sciences, XP-002076355, vol. 62, pp. 1561-1565, 1998, Elsevier Publication, USA.
Ferguson, S.S.G., et al.,Role of Phosphorylation in Agonist-promoted β2-Adrenergic Receptor Sequestration, Journal of Biological Chemistry, vol. 270, No. 42, Oct. 20, 1995, pp. 24782-24789, The American Society for Biochemistry and Molecular Biology, Inc., USA.
Mhaouty-Kodja, S., et al.,Constitutively Active Alpha-1b Adrenergic Receptor Mutants Display Different Phosphorylation and Internalization Features, Molecular Pharmacology, vol. 55, No. 2, Feb. 1999, pp. 339-347, The American
Barak Lawrence S.
Caron Marc G.
Laporte Stephane A.
Oakley Robert H.
Duke University
Hutchison & Mason PLLC
Ulm John
LandOfFree
Modified G-protein coupled receptors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Modified G-protein coupled receptors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Modified G-protein coupled receptors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3532696